The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients
about
Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-AnalysisInflammation based regulation of cancer cachexiaModified inflammation-based score as an independent malignant predictor in patients with pulmonary focal ground-glass opacity: a propensity score matching analysisThe PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal CancerC-reactive protein/albumin ratio as prognostic score in oral squamous cell carcinoma.A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.Prognostic significance of Glasgow prognostic score in patients undergoing esophagectomy for esophageal squamous cell carcinoma.Immunization-based scores as independent prognostic predictors in soft tissue sarcoma patients.Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients.Modified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) Patients.Does the modified Glasgow Prognostic Score (mGPS) have a prognostic role in esophageal cancer?Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer.Tumour inflammatory response: adding fuel to the fire?Albumin and Fibrinogen Combined Prognostic Grade Predicts Prognosis of Patients with Prostate Cancer.Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer.Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma.
P2860
Q26786160-B9D8EE71-6222-4608-8A8A-36DD4BCCB987Q33615916-C9EA3C74-907E-4A50-BA8D-A9BA55259D8DQ36449051-F3E8D4FC-0807-453B-91AA-95D60313A8D9Q37206114-4F2AAAEA-A4D6-4124-9631-4E8D2C3A6E76Q37408199-57BEE851-306A-47F1-AAE8-73635A64247AQ37465628-9B15C1FD-3E0B-4828-BEEB-17851221A49EQ37634819-DB1650EC-C568-4C3A-A3F1-4BF2BE8678F4Q37726404-F56648E1-5A46-4F00-87E8-CE86D0B536D4Q38399545-8E93070D-164E-45B5-A922-F1E7EF7F1196Q38642286-FDB50797-23CB-4C2D-B348-91131E73287DQ39897201-4937CF9F-C9DE-4462-8307-55EEB622641EQ40572565-E42DE4C7-0B5E-4EE3-B286-7C50D82BDC13Q41904274-880E210A-9A93-4C45-A03F-90761B11E051Q47162057-F0A5D070-8C64-49CC-9BB5-C2575334998FQ47299558-99E25381-2763-45A7-8F46-0E3BD3400F0DQ53505738-BAF1E20B-A1DB-4BAC-A9E5-3FA83F6570C0
P2860
The modified Glasgow prognostic score in prostate cancer: results from a retrospective clinical series of 744 patients
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The modified Glasgow prognosti ...... linical series of 744 patients
@ast
The modified Glasgow prognosti ...... linical series of 744 patients
@en
The modified Glasgow prognosti ...... linical series of 744 patients
@nl
type
label
The modified Glasgow prognosti ...... linical series of 744 patients
@ast
The modified Glasgow prognosti ...... linical series of 744 patients
@en
The modified Glasgow prognosti ...... linical series of 744 patients
@nl
prefLabel
The modified Glasgow prognosti ...... linical series of 744 patients
@ast
The modified Glasgow prognosti ...... linical series of 744 patients
@en
The modified Glasgow prognosti ...... linical series of 744 patients
@nl
P2093
P2860
P356
P1433
P1476
The modified Glasgow prognosti ...... linical series of 744 patients
@en
P2093
Billy Sloan
Hing Leung
Karen Smith
Kashif Shafique
Michael J Proctor
P2860
P2888
P356
10.1186/1471-2407-13-292
P407
P577
2013-06-17T00:00:00Z
P5875
P6179
1032169326